Intracellular mitochondrial transfer in ischemic stroke: Mechanisms and therapeutic application

Area of Science:

• Cellular Biology
• Neuroscience
• Regenerative Medicine

Background:

• Ischemic stroke (IS) treatment is evolving towards cytoprotection, focusing on cell rescue and integrity.
• Intracellular mitochondrial transfer is an intrinsic IS response crucial for mitigating neural damage.
• Stem cell-derived mitochondrial transplantation is a promising therapeutic strategy for IS.

Purpose of the Study:

• Review IS-induced mitochondrial dysfunction.
• Explore endogenous intracellular mitochondrial transfer mechanisms.
• Summarize advances in stem cell-derived mitochondrial transplantation for IS.

Main Methods:

• Literature review of mitochondrial transfer in ischemic stroke.
• Analysis of endogenous mitochondrial transfer modes and mechanisms.
• Evaluation of stem cell-derived mitochondrial transplantation therapies.

Main Results:

• Mitochondrial transfer plays a dual role in neural cell fate and recovery post-IS.
• Healthy cells can transfer intact mitochondria to revitalize damaged cells.
• Damaged cells may release dysfunctional mitochondria, propagating injury or being cleared.

Conclusions:

• Enhancing healthy mitochondrial transfer or preventing damaged mitochondrial release shows therapeutic potential for IS.
• Mitochondrial transplantation offers a novel avenue for IS treatment.
• Understanding mitochondrial dynamics is critical for improving IS outcomes.